HEALTHEQUITY (HQY) Form 144: 2,393 shares, $211,942 sale notice

Form 144 notice for HEALTHEQUITY, INC.

Rhea-AI Filing Summary

Form 144 notice for HEALTHEQUITY, INC. (HQY) reports a proposed sale of 2,393 shares of common stock on 10/06/2025 through Morgan Stanley Smith Barney on NASDAQ, with an aggregate market value of $211,941.69. The shares were acquired by the selling person through restricted stock vesting: 1,788 shares vested on 09/06/2023 and 605 shares vested on 03/27/2024; the sale is identified as compensation proceeds. The filer reports no securities sold in the past three months and certifies no undisclosed material adverse information.

Positive

• Full disclosure of share counts, acquisition dates, and sale broker helps transparency
• Securities were acquired via restricted stock vesting, a standard compensation mechanism

Negative

• No prior sales reported in past three months reduces recent liquidity history for this holder

Insights

Equity Compliance Analyst

Insider sale via vested restricted shares; routine compliance filing.

The notice records a proposed disposition of $211,941.69 for 2,393 shares to be executed on 10/06/2025 through Morgan Stanley Smith Barney. The underlying shares were issued as restricted stock and vested on 09/06/2023 and 03/27/2024, and the payment source is listed as compensation, which aligns with typical executive or employee equity compensation exits.

Primary compliance considerations include confirming aggregation with other related-party sales and ensuring the seller's representation about absence of undisclosed material information remains accurate as of the filing date. Monitor whether additional Form 4 or Form 144 filings follow near 10/06/2025 to track execution and any public disclosures of related trading plans.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does HEALTHEQUITY (HQY) Form 144 report?

It reports a proposed sale of 2,393 shares valued at $211,941.69 to be sold on 10/06/2025 on NASDAQ through Morgan Stanley Smith Barney.

How were the HQY shares acquired that are being sold?

The shares were acquired through restricted stock vesting: 1,788 shares on 09/06/2023 and 605 shares on 03/27/2024.

Does the filing indicate the sale proceeds source for HQY Form 144?

Yes. The filing lists the nature of payment as compensation for both vested tranches.

Are there any other HQY sales reported by this person in the past three months?

The Form 144 indicates Nothing to Report for securities sold during the past three months.

Which broker is handling the proposed HQY sale?

The broker listed is Morgan Stanley Smith Barney, address in Purchase, NY.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/08/2025 - 05:15 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001638683
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	HEALTHEQUITY, INC.
SEC File Number	001-36568
Address of Issuer	15 WEST SCENIC POINTE DRIVE SUITE 100 DRAPER UTAH 84020
Phone	801.727.1000
Name of Person for Whose Account the Securities are To Be Sold	James M. Lucania
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney 2000 Westchester Ave Purchase NY 10577-2530	2393	211941.69	86156334	10/06/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	09/06/2023	Restricted Stock Vesting	ISSUER			1788	10/06/2025	Compensation
Common Stock	03/27/2024	Restricted Stock Vesting	ISSUER			605	10/06/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of a tax withholding obligation to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
Date of Notice	10/08/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ James M. Lucania
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)